A Phase 1 interventional study of Ropivacaine 0.25%-NaCl 0.9% Injectable Solution in Inguinal Hernia and Pain, Postoperative, sponsored by Egymedicalpedia. Completed at 1 site in Egypt. Open to participants aged 30 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-09-22.
Sponsored by Egymedicalpedia · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 45 studies in Hernia, Inguinal with a site in Egypt — 16 open to participants now, 17 under way, 1 of them phase 3. Hernia, Inguinal · Egypt.
Among the 45 studies in Hernia, Inguinal with a site in Egypt, this one is the 18th largest by enrollment of the 43 interventional ones that give a count, is one of 3 that started in 2021, is one of 3 in phase 1, and was the 13th registered.
545 studies on the registry are indexed under Hernia, Inguinal; 93 are open to participants now.
Browse Hernia, Inguinal studies →16 of the 45 studies in Hernia, Inguinal with a site in Egypt are open now. Recruiting first, the newest first:
Kasr El Aini Hospital · Sites in Egypt
Ages 18+ · Men only · Healthy volunteers
Menoufia University · Sites in Egypt
Ages 2–7
Sohag University · Sites in Egypt
Sohag University · Sites in Egypt
Ages 2–6 · Healthy volunteers
Assiut University · Sites in Egypt
Ages 18+
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 56 Hernia, Inguinal studies recruiting now, 30 (54%) set no upper age limit and 17 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.
This study: 30 Years to 45 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
45 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 1 · Phase 3 2
First in 2008; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 64 is below the median of 90 across 397 interventional studies indexed under Hernia, Inguinal.
Median enrollment 60 across the 43 interventional studies, 75 across the 2 observational. Of the 27 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 45 have an industry lead sponsor. The 10 most frequent:
Egymedicalpedia is the lead sponsor of 58 studies on the registry; 13 are open to participants now.
Egymedicalpedia has 2 studies filed under Hernia, Inguinal — fewer than ten, so there is no comparison to draw.
5 of the studies in Hernia, Inguinal with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07343570Phase 3Al-Azhar UniversityComparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia Repair. | 2026-11-30 |
| NCT07926269Beni-Suef UniversityPosterior Versus Transmuscular Quadratus Lumborum Block in Children Undergoing Lower Abdominal Surgery | 2027-04 |
| NCT07916233Beni-Suef UniversityLumbar ESP Block Versus TAP Block for Postoperative Pain Control in Children Undergoing Open Inguinal Hernia Repair | 2027-04 |
| NCT07853586Menoufia UniversityUltrasound-guided Quadratus Lumborum Block Versus Erector Spinae Plane Block for Postoperative Analgesia in Children Undergoing Elective Open Lower Abdominal Surgeries | 2027-07 |
| NCT07918430Kasr El Aini HospitalPrimary Sac Abandonment and Distal Sac Fixation vs Complete Sac Dissection for Inguinoscrotal Hernias | 2027-08-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 45 studies in Hernia, Inguinal with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Buprenorphine intravenous, sublingual, and transdermal patches have been researched for their antihyperalgesic effects, although peripherally mediated effects have not been examined in Egypt surprisingly
This prospective, randomized, double-blind controlled trial involved 88 patients who were scheduled for inguinal hernia surgery followed by a TAP block. Patients were allocated into group B (n= 44) received 20 ml of 0.25% Ropivacaine for TAP block; group BR (n= 44) received 20 ml of 0.25% Ropivacaine containing 300 μg of buprenorphine for TAP Block. The primary outcome of the study was the analgesic and antihyperalgesic effect of buprenorphine compared to the control group. The duration of analgesia, analgesic consumption, postoperative pain scores at rest and sitting up to 48 hrs, and effect on wound hyperalgesia at 24 and 48 hrs were evaluated. Secondary outcomes of the study include incidence of side effects and TAP block-related complications were recorded. Effect of buprenorphine on patients with predicted high pain scores and incidence of persistent postoperative pain were also determined.
A transversus abdominis plane (TAP) block provides analgesia of the anterior and lateral abdominal wall below the umbilicus by blocking the T6-L1 segmental nerves as they lie within the fascial plane between the transversus abdominis and internal oblique muscles: bilateral block for midline abdominal incision. It was first described in 2001 by Rafi as a traditional blind landmark technique using the lumbar triangle of Petit. Local anesthetic is then injected between the internal oblique and transverse abdominis muscles just deep the fascial plane, the plane through which the sensory nerves pass
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Candidates received 20 ml of 0.25% ropivacaine for TAP block
Drug: Ropivacaine 0.25%-NaCl 0.9% Injectable Solution
Candidates received 20 ml of 0.25% ropivacaine and 300 μg of buprenorphine, respectively, for the TAP block.
Drug: Ropivacaine 0.25%-NaCl 0.9% Injectable Solution
The pain level of the cases is evaluated by means of the digital pain (numeric rating) scale from 0 to 10 in which 0 means "no pain" and 10 means "the worst pain" as well as the duration of pain relief and the need for another dose of the same analgesic or other. The pain level is evaluated again if it is present.
Also known as: buprenorphine 300 μg
Post Operative Pain
The pain level of the cases is evaluated by means of the digital pain as the 11-point visual analog scale (VAS) whereas 0-Represents no pain, 10 - Worst imaginable pain), as well as the 11-point VAS-A (0-Represents no anxiety, 10 - Highest anxiety)
Time frame: 2 hours after the operation upto 48-hour analgesic after surgery
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jan 2021 to primary completion in May 2022, 16 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ropivacaine